Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
99%
Hip Fracture
77%
Antibiotics
73%
Case-Control Study
65%
Glucocorticoid
54%
Disease
52%
Fragility Fracture
50%
Spine Fracture
41%
Statin (Protein)
38%
Femur Fracture
37%
Infection
35%
Cardiovascular Disease
31%
Population Study
31%
Bisphosphonic Acid Derivative
30%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
27%
Antibiotic Agent
26%
Chronic Obstructive Lung Disease
25%
Rheumatoid Arthritis
24%
Atrial Fibrillation
23%
Multiple Sclerosis
21%
Warfarin
21%
Heart Infarction
20%
Prevalence
19%
Antidepressant
18%
Acetylsalicylic Acid
14%
Thiazolidinedione
14%
Adverse Drug Reaction
14%
Etidronic Acid
14%
Anticonvulsive Agent
14%
Adverse Event
14%
Asthma
14%
Upper Respiratory Tract Infection
13%
Non-Steroidal Anti-Inflammatory Drug
13%
Randomized Clinical Trial
12%
Antipsychotic
12%
Alendronic Acid
12%
Pandemic
11%
Beta 2 Adrenergic Receptor Stimulating Agent
11%
Observational Study
11%
Venous Thromboembolism
11%
Typical Antipsychotic
10%
Chronic Atrial Fibrillation
10%
Long Term Exposure
10%
Sepsis
10%
Bronchodilating Agent
10%
Respiratory Tract Disease
10%
Side Effect
10%
Anticoagulant Agent
9%
Malignant Neoplasm
9%
COX-2 Inhibitor
9%
Medicine and Dentistry
General Medicine
100%
Anti-biotics
72%
Electronic Health Record
60%
Cohort Analysis
49%
Apoplexy
43%
Electronic Patient Record
35%
Infection
35%
Cohort Effect
32%
Diseases
30%
Hip Fracture
27%
Odds Ratio
26%
COVID-19
25%
Hazard Ratio
24%
Hip Replacement
24%
Case-Control Study
24%
Cluster Randomized Trial
23%
Drug Therapy
22%
Atrial Fibrillation
19%
Cardiovascular Disease
17%
Cardiovascular System
16%
Gene Linkage
16%
Antibiotic Resistance
16%
Consultation
15%
Prevalence
15%
Malignant Neoplasm
15%
Retrospective Cohort Study
15%
Fragility Fracture
14%
Total Knee Arthroplasty
13%
Hip
13%
Asthma
13%
Population Research
12%
Secondary Prevention
12%
Meta-Analysis
12%
Statin
12%
Corticosteroid Therapy
11%
Spine Fracture
11%
Clinician
11%
Upper Respiratory Tract Infection
11%
Knee Replacement
10%
Sepsis
10%
Health Inequality
10%
Secondary Care
10%
Venous Thromboembolism
10%
Body Mass Index
10%
Observational Study
9%
Myocardial Infarction
9%
Health Care Cost
9%
Chronic Obstructive Pulmonary Disease
9%
Mortality
9%
Osteoporosis
9%
Nursing and Health Professions
Primary Medical Care
64%
General Practice
59%
Clinical Practice
32%
Electronic Health Record
32%
Cohort Analysis
31%
Infection
22%
Antibiotic Agent
19%
General Practitioner
17%
Case-Control Study
15%
Warfarin
15%
Practice Guideline
13%
Decision Support System
11%
Hip Fracture
10%
Atrial Fibrillation
10%
Obstructive Lung Disease
10%
International Normalized Ratio
10%
Personal Health Record
10%
Respiratory Tract Infection
10%
Confidence Interval
9%
Antimicrobial Resistance
9%
Secondary Prevention
9%
Clinician
9%
Anticoagulation
8%
Disease
8%
Odds Ratio
7%
Cost Effectiveness Analysis
7%
Healthcare System
7%
Total Hip Prosthesis
7%
Acute Coronary Syndrome
7%
Chronic Atrial Fibrillation
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Logistic Regression Analysis
6%
Diagnosis
6%
Drug Therapy
6%
Medical Record
6%
Statin (Protein)
5%
Hazard Ratio
5%
Long Term Exposure
5%
Intervention Research
5%
Randomization
5%
Mortality Rate
5%
Thematic Analysis
5%
